NVO Novo Nordisk A/S

P/E 9.19
Forward P/E 14.08
Price/Sales 0.523
Beta 0.384
Div Yield 0.046%
Market Cap --

Company Analysis

Latest News

Novo Nordisk A/S Q1 2026 Earnings Preview: What Analysts Expect on May 06, 2026

Consensus forecasts peg Q1 revenue at $11.84 billion and EPS at $0.87, as the stock trades at $164.20 against an average analyst target of $188.50. Investors...